1. Task force reaffirms statin safety

   Guideline 24 May 2014 Pages: 1 - 1

2. FDA reveals new safety data on dabigatran

   News item 24 May 2014 Pages: 2 - 2

3. No revision to package insert precautions for clemastine

   News item 24 May 2014 Pages: 2 - 2

4. Olmesartan label updated with warning on spure-like enteropathy

   News item 24 May 2014 Pages: 2 - 2

5. Japan revises reporting system for quasi-drugs and cosmetics

   News item 24 May 2014 Pages: 2 - 2

6. Irish Medicines Board restricts use of metoclopramide

   News item 24 May 2014 Pages: 2 - 2

7. Acute β-blockade: risk of adverse respiratory effects in asthma

   Review 24 May 2014 Pages: 3 - 3

8. Temozolomide: risk of hepatic injury

   News item 24 May 2014 Pages: 3 - 3

9. Antibiotic use in infancy increases risk of childhood asthma

   Clinical study 24 May 2014 Pages: 3 - 3

10. Risk of cardiac side effects with domperidone, MHRA restricts use

    News item 24 May 2014 Pages: 3 - 3

11. Tdap vaccine during pregnancy: no increased risk of adverse events

    Clinical study 24 May 2014 Pages: 4 - 4

12. Testosterone: negative effects on cognitive function in AD

    Clinical study 24 May 2014 Pages: 4 - 4

13. Aciclovir

    Case report 24 May 2014 Pages: 5 - 5

14. Alendronic acid/denosumab

    Case report 24 May 2014 Pages: 5 - 5

15. Alcohol

    Case report 24 May 2014 Pages: 5 - 5

16. Aclarubicin/cytarabine/granulocyte colony-stimulating factors

    Case report 24 May 2014 Pages: 5 - 5

17. Adefovir/lamivudine

    Case report 24 May 2014 Pages: 5 - 5

18. Amlodipine

    Case report 24 May 2014 Pages: 6 - 6

19. Aminoglycosides/ethylene glycol/furosemide

    Case report 24 May 2014 Pages: 6 - 6

20. Amisulpride/risperidone/zuclopenthixol

    Case report 24 May 2014 Pages: 6 - 6

21. Allopurinol

    Case report 24 May 2014 Pages: 6 - 6

22. Antidepressants/benzodiazepines

    Case report 24 May 2014 Pages: 7 - 7

23. Antiretrovirals/sorafenib

    Case report 24 May 2014 Pages: 7 - 7

24. AN 2728

    Case report 24 May 2014 Pages: 7 - 7

25. Ascorbic acid

    Case report 24 May 2014 Pages: 8 - 8

26. Antituberculars

    Case report 24 May 2014 Pages: 8 - 8

27. Aripiprazole

    Case report 24 May 2014 Pages: 8 - 8

28. Antituberculars

    Case report 24 May 2014 Pages: 8 - 8

29. Baclofen

    Case report 24 May 2014 Pages: 9 - 9

30. Azathioprine

    Case report 24 May 2014 Pages: 9 - 9

31. Asenapine

    Case report 24 May 2014 Pages: 9 - 9

32. Azathioprine

    Case report 24 May 2014 Pages: 9 - 9

33. Atorvastatin

    Case report 24 May 2014 Pages: 9 - 9

34. Azithromycin

    Case report 24 May 2014 Pages: 9 - 9

35. Balsalazide

    Case report 24 May 2014 Pages: 10 - 10

36. BCG vaccine

    Case report 24 May 2014 Pages: 10 - 10

37. Bortezomib

    Case report 24 May 2014 Pages: 10 - 10

38. Barium

    Case report 24 May 2014 Pages: 10 - 10

39. BCG

    Case report 24 May 2014 Pages: 10 - 10

40. Belimumab

    Case report 24 May 2014 Pages: 10 - 10

41. Calcifediol

    Case report 24 May 2014 Pages: 11 - 11

42. Botulinum toxin A

    Case report 24 May 2014 Pages: 11 - 11

43. Bortezomib/dexamethasone

    Case report 24 May 2014 Pages: 11 - 11

44. Calcium gluconate

    Case report 24 May 2014 Pages: 11 - 11

45. Carbamazepine/etonogestrel interaction

    Case report 24 May 2014 Pages: 12 - 12

46. Cefazolin/metronidazole

    Case report 24 May 2014 Pages: 12 - 12

47. Cetuximab

    Case report 24 May 2014 Pages: 12 - 12

48. Carbamazepine

    Case report 24 May 2014 Pages: 12 - 12

49. Chlorpromazine

    Case report 24 May 2014 Pages: 13 - 13

50. Chlorzoxazone

    Case report 24 May 2014 Pages: 13 - 13